Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

This study has been completed.
Ibermutuamur M.A.T.E.P.S
Information provided by:
AstraZeneca Identifier:
First received: July 14, 2008
Last updated: September 12, 2008
Last verified: July 2008
Retrospective cohort study to evaluate the effect of the association of PPIs with NSAIDs in work leave time.

Sprain of Ankle

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Total work leave time [ Time Frame: Jan 2007 to Dec 2007 ]

Secondary Outcome Measures:
  • GI complications [ Time Frame: Jan 2007 to Dec 2007 ]
  • Direct medical costs [ Time Frame: Jan 2007 to Dec 2007 ]

Enrollment: 6356
Study Start Date: April 2008
Study Completion Date: August 2008
Patients with sprain of ankle treated with NSAID


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Data base of patients with work leave due to a sprain of ankle

Inclusion Criteria:

  • Work leave due to a sprain of ankle

Exclusion Criteria:

  • (none)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00717119

Research Site
Madrid, Spain
Sponsors and Collaborators
Ibermutuamur M.A.T.E.P.S
Study Director: Javier N Rivero, MSc Epidemiology Unit. AstraZeneca
  More Information

Responsible Party: Mónica Tafalla/MD, PhD, AstraZeneca Pharmaceuticals Identifier: NCT00717119     History of Changes
Other Study ID Numbers: NIS-GES-DUM-2008/3
Study First Received: July 14, 2008
Last Updated: September 12, 2008

Keywords provided by AstraZeneca:

Additional relevant MeSH terms:
Proton Pump Inhibitors
Anti-Inflammatory Agents, Non-Steroidal
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents processed this record on May 25, 2017